Tandem Diabetes Care, Inc. (TNDM) Shares Tick Up after Upgrade at Zacks Investment Research

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares rose in value on Wednesday January 18 on lower trade volume than normal after a number of analysts weighed in on the investing value of the stock with a upgraded rating.

Meanwhile, in early trade today, the S&P 500 SPX, +0.00% was off 2 points, or 0.1%, at 2,265, shortly after open. The Nasdaq Composite COMP, +0.20% was flat at 5,537. The Dow Jones Industrial Average DJIA, -0.20% slipped 54 points or 0.3%, to 19,770.

Analysts at Zacks Investment Research upgraded shares of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) from Sell to Hold today. Zacks Investment Research currently has a rating of Hold on the stock. As a means of comparison, a number of other analysts have issued reports on the company in recent days, and the company has secured a consensus one-year price target of $5.67, higher than the opening price of $2.95, a difference of 20.40 percent. Tandem Diabetes Care, Inc. stock has a 52-week high of $11.30. Share prices sometimes get a bounce to the upside when analysts upgrade a stock.

Yesterday Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares last traded at $2.78, which is an increase of $0.03 over the previous closing price. Opening at $2.95, they varied from $2.75 and $3.00 throughout the day.

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) currently has a market cap of 85.22M.

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) Average Daily Trading Volume

The stock’s average daily volume is 564,924 shares out of a total float 18,671,000 and some 97,829 shares traded hands yesterday, 44 percent lower than the norm. lower than normal. Look for trading volume to pick up in the coming days as momentum traders often use increases in trading volume to identify heavy volume accumulation or distribution by institutional investors.

As with all potential breakouts, investors look for volume to be at least 40%-50% higher than normal on the breakout to show that fund managers and other professional investors are jumping in.

Institutional sponsorship commonly refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These instituitional investors retain substantial teams of analysts researching thousands of stocks. So watching their interests is a good way to make sure you are buying the right stocks.

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By tracking the activity of these professional investors—and the moving averages they affect—it allows for traders to make more effective decisions on trades.

Trades for Tandem Diabetes Care, Inc. (NASDAQ: TNDM) have ranged from $1.60 – 11.300, and the stock now has a 50-day MA of $2.28 and 200-day MA of $5.33. Today’s last price is 75.39%% lower than the 52 week high of $11.30.

Earnings growth is an important factor to look at when investing in stocks and investors identify companies that have increased their earnings by at least 25% over the past 3 years.

DISCLOSURE: The views and opinions expressed in this article do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Latest News

Leave a Reply